OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
Johannes Lübke, Nicole Naumann, Georgia Metzgeroth, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2077-2085
Open Access | Times Cited: 8
Johannes Lübke, Nicole Naumann, Georgia Metzgeroth, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2077-2085
Open Access | Times Cited: 8
Showing 8 citing articles:
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries
Johannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Leukemia (2024) Vol. 38, Iss. 4, pp. 810-821
Open Access | Times Cited: 5
Johannes Lübke, Deborah Christen, Juliana Schwaab, et al.
Leukemia (2024) Vol. 38, Iss. 4, pp. 810-821
Open Access | Times Cited: 5
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee
Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Leukemia (2024)
Closed Access | Times Cited: 5
Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Leukemia (2024)
Closed Access | Times Cited: 5
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
Peter Valent, Cem Akin, Michel Arock, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15125-15125
Open Access | Times Cited: 2
Peter Valent, Cem Akin, Michel Arock, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15125-15125
Open Access | Times Cited: 2
Advanced systemic mastocytosis—Revised classification, new drugs and how we treat
Animesh Pardanani, Kaaren K. Reichard, Ayalew Tefferi
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 402-414
Closed Access | Times Cited: 2
Animesh Pardanani, Kaaren K. Reichard, Ayalew Tefferi
British Journal of Haematology (2023) Vol. 204, Iss. 2, pp. 402-414
Closed Access | Times Cited: 2
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Helen T. Chifotides, Prithviraj Bose
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C‐finding treated with midostaurin
Maël Heiblig, C. Gourguechon, Philippe Guilpain, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 11, pp. 2127-2139
Open Access
Maël Heiblig, C. Gourguechon, Philippe Guilpain, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 11, pp. 2127-2139
Open Access
Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
Nicola Humphry
EMJ Hematology (2023), pp. 27-34
Open Access
Nicola Humphry
EMJ Hematology (2023), pp. 27-34
Open Access
Untangling Systemic Mastocytosis: An Update on Challenges in the Diagnosis and Treatment of Myeloid Neoplasms with Systemic Mastocytosis
Éric Solary, Julien Rossignol, Andreas Reiter, et al.
EMJ Hematology (2023), pp. 27-34
Open Access
Éric Solary, Julien Rossignol, Andreas Reiter, et al.
EMJ Hematology (2023), pp. 27-34
Open Access
